Par Drugs and Chemicals Limited — Board Meeting, 22-10-2024: Outcome of Board Meeting

Par Drugs and Chemicals Limited reported its unaudited financial results for the half year ending September 30, 2024. Revenue increased to ₹5,726.25 lakhs, with a profit of ₹1,112.89 lakhs. The Board approved the financial results, authorized key executives to sign them, and noted positive investor grievance handling. No unresolved complaints were reported. Advertisements regarding the financial results will be published in major newspapers. The trading window will reopen 48 hours post-announcement.